Phase III study results on miconazole Lauriad presented by BioAlliance Pharma
Links shared publicly online about this topic.
- 1,625total visits
Phase III study results on miconazole Lauriad presented by BioAlliance Pharma
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented results on miconazole Lauriad® at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) in Philadelphia (October 29 " November 1st).
View full resource at news-medical.net
Tags: Infectious Disease, Infection, HIV, AIDS, STD, Cancer, Disease and Condition, Pharma
Most Recently Shared on November 5, 2009 at 5:47 am By:
HIV/AIDS News: Phase III study results on miconazole Lauriad presented by BioAlliance Pharma: Bio.. http://bit.ly/6eX0G
Phase III results of Lauriad presented at the 49th Annual ICAAC
news-medical.net — “BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.” View full resource at news-medical.net
Most Recently Shared on September 16, 2009 at 1:01 am By:
HIV/AIDS News: Phase III results of Lauriad presented at the 49th Annual ICAAC: BioAlliance Pharma.. http://bit.ly/3w5HAC
Advertisement
